Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Pharma Manufacturers Across Asia, Europe and the USA: A Buyer's Guide (2026)

Mitul Agarwal
Written by Mitul Agarwal · B.Pharm, MBA
Founder & Head of Business Development · 25+ years in international pharmaceutical BD&L
Published 6 September 2025 · Reviewed and updated 19 October 2026
Pharma Manufacturers Across Asia, Europe and the USA: A Buyer's Guide (2026)

Buyers, distributors and licensing teams often start with a list of famous pharmaceutical companies and ask, "Can I buy from them?" The honest answer is sometimes, but rarely in the way people expect. What matters more than a company's name is the kind of manufacturer it is, where its products are actually made, and the route it uses to sell into your market. This guide sets out how the global industry is organised across Asia, Europe and the United States, and how to approach each type of manufacturer.

Five kinds of pharmaceutical manufacturer

Almost every manufacturer you will deal with fits one of these groups. Each sells in a different way, so it pays to know which one you are talking to.

TypeWhat they sellHow buyers usually deal with them
Innovators (originators)Patented brands, biologics, vaccines; some older brandsThrough the company's own country office or its appointed distributor; sometimes by licensing a brand for a market it does not serve
Large multinational generic groupsBroad generic and biosimilar portfolios in many countriesTenders, national distributors, and supply or licensing agreements
Regional and national generic manufacturersGenerics registered in their home market and selected export marketsDirect supply, dossier licensing, private label and contract manufacturing
Contract manufacturers (CDMOs and CMOs)Manufacturing and development services, not their own brandsDevelopment and supply agreements for your product, under your name
API and intermediate manufacturersActive ingredients, intermediates and key starting materialsSupply agreements backed by a DMF, CEP or ASMF and a letter of access

How the regions differ

A company's head office tells you little about where a product is made. Most large manufacturers run plants on several continents. Still, each region has clear strengths.

RegionTypical strengthsWhat to check
South AsiaGeneric finished doses and APIs at scale, a large number of US FDA– and EU-inspected sites, ready dossiers, competitive contract manufacturingApproval of the specific site, not the company; dossier ownership; data integrity history
ChinaKey starting materials, intermediates, fermentation and commodity APIs; fast-growing innovation and biologics capacityDMF or CEP status, EU written confirmation, inspection history, change control
Japan and South KoreaInnovative medicines, high-quality generics for home markets, very large biologics manufacturing capacityExport focus and local partner arrangements; lead times
Western EuropeInnovator headquarters, complex and high-potency APIs, peptides, sterile manufacturing, strong regulatory documentationPrice versus supply security; capacity for small volumes
Central and Eastern EuropeGenerics for EU and CIS markets, competitive formulation capacityWhich markets each product is registered in
United StatesInnovator and biotech companies, large generic and sterile injectable makers, advanced therapiesExport licensing, US pricing and supply priorities

So, can you buy directly from a big manufacturer?

A large company will seldom take a small order from a distributor it does not know. These routes tend to work better:

  • Go through the local office or appointed distributor. Branded medicines are normally sold in each country through the company's own office or a distributor it has appointed. If there is none in your market, ask whether you could become one, and be ready to show your licence, coverage and registration capability.
  • Use tenders and wholesale channels for generics. Large generic groups sell heavily through public tenders and national wholesalers.
  • Ask about licensing. Many manufacturers will license a dossier or a brand for a country they do not plan to enter themselves. It is often the quickest legitimate route to a registered product.
  • For your own brand, go to a contract manufacturer. An innovator is usually the wrong door for private label or development work. A CDMO is the right one.
  • For unregistered medicines for named patients, use a licensed named-patient or import route rather than ordinary trade channels.

Check the paperwork before you pay

Whoever you buy from, ask for:

  • the GMP certificate for the manufacturing site, verified with the issuing authority;
  • the certificate of pharmaceutical product (CoPP) or free-sale certificate where your regulator needs one;
  • a certificate of analysis for each batch;
  • for anyone claiming to represent a manufacturer, a signed and current letter of authorisation, which you then confirm with the manufacturer directly.

If someone claims to represent a well-known company but cannot produce that letter, walk away. Our guide on how to verify a pharmaceutical supplier covers the checks in detail.

Name versus fit

A household name is reassuring, but it does not tell you whether a product is registered in your market, whether supply is available, or whether the price fits your tender. For most generic and private-label needs, the best partner is a well-run manufacturer whose site approvals, dossier and capacity match your market — and that is often a company you have never heard of.

How we can help

Tell us the product, strength, pack and destination market, and we connect you with GMP-certified manufacturers and authorised suppliers who can actually quote, across Asia, Europe and the Americas. Post a request for a quote, read our guide to choosing a contract manufacturer, or see how to find and qualify a CDMO in India. For active ingredients, use our API enquiry form.


Frequently Asked Questions(FAQs)

Can a distributor buy medicines directly from a large pharmaceutical manufacturer?

Usually not for small or first orders. Large manufacturers sell through their own country offices or appointed distributors, through tenders and wholesalers, or by licensing a product for a market they do not serve. Ask about becoming an appointed distributor if there is none in your country.

What is the difference between an originator and a generic manufacturer?

An originator developed the medicine and usually holds or held its patents. A generic manufacturer makes an equivalent version after patents and exclusivity expire, and registers it on the basis of bioequivalence or comparability.

Does a company's head office show where its medicines are made?

No. Most large manufacturers run plants in several countries. The GMP certificate and the registration documents show the actual manufacturing site, and that is what regulators and buyers should check.

What documents should I ask a pharmaceutical manufacturer for?

The site's GMP certificate, a certificate of pharmaceutical product or free-sale certificate where required, a certificate of analysis for each batch, and, for any intermediary, a signed letter of authorisation that you confirm with the manufacturer.

Should I use a big-name manufacturer for my private-label product?

Usually not. Innovators rarely do private label. A contract manufacturer with the right dosage form, site approvals and capacity for your market is normally the better and faster choice.

Disclaimer: The information presented in this article is for informational and educational purposes only. While every effort has been made to ensure data accuracy and reliability, readers are advised to independently verify all figures, regulations, and market insights before making any business or investment decisions.

Category: Pharma Blogs

← Back to All Articles

 

Realated Articles

Pharma Manufacturers Across Asia, Europe and the USA: A Buyer's Guide (2026)
Pharmaceutical Sourcing for Southeast Asia: A Buyer's Guide to Medicines, APIs and CDMOs (2026)
Read More
Pharma Manufacturers Across Asia, Europe and the USA: A Buyer's Guide (2026)
Latin America Pharmaceutical Market: A Comprehensive Guide for Global Pharma Buyers
Read More
Pharma Manufacturers Across Asia, Europe and the USA: A Buyer's Guide (2026)
Generic API Suppliers in India and China: How to Compare and Qualify Them (2026)
Read More

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us